Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Contraceptives Market Size Changed, over the years?

Over the years, the contraceptives market has seen substantial growth. It is projected to increase from $27.92 billion in 2024 to $30.05 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. Factors contributing to the growth during the historic period include the introduction of the birth control pill, improved knowledge and education on contraception, legal and societal adjustments in favour of reproductive rights, global endeavors to control population, and the increased preference for generic and more affordable drugs and devices.

How Much Will the Contraceptives Market Be Worth in 2029?

In the coming years, the contraceptives market is projected to experience robust growth, reaching $40.89 billion by 2029 with a compound annual growth rate (CAGR) of 8.0%. The expected expansion during this period is due to factors such as increased focus on male contraceptives, improved availability of contraceptives in developing nations, the incorporation of digital health technologies in contraception, heightened demand for long-acting reversible contraceptives (LARCS), and easier access to over-the-counter medicines online. Furthermore, noticeable trends for the future include advancements in contraceptive technology, a move towards non-hormonal and natural contraception methods, broader over-the-counter availability for certain contraceptives, a preference for user-friendly and discreet contraception options, and the incorporation of telemedicine for contraceptive counseling and prescriptions.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6920&type=smp

Which is the Largest Company in the Contraceptives Market?

Major companies operating in the contraceptives market include Merck & Co. Inc., Bayer AG, Church & Dwight Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Medisafe Distribution Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd.

What Are the Main Market Drivers in the Contraceptives Industry?

Increased instances of sexually transmitted infections (STIs) are fuelling a higher demand for contraceptives. These infections, commonly known as STDs, are usually transmitted between people during sexual activity. This includes any type of sexual interaction, including anal, oral, and vaginal sex, but STDs can also be spread through other types of close physical contact. Contraceptives play a crucial role in mitigating the spread of STDs such as herpes and HPV, typically through skin-to-skin contact. Evidence of this comes from the Minnesota Department of Health who reported in May 2023 that primary and secondary syphilis cases had risen by 19% in 2022, up from 564 cases in 2021 to 676 in 2022. Additionally, the department reported that 20 incidents of congenital syphilis in new-borns were documented in 2022, a 42 % increase from the 14 cases recorded in 2021. Therefore, this growth in STIs is expected to stimulate an increase in contraceptive use during the forecast period.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=6920&type=smp

How Is the Contraceptives Market Segments Structured?

The contraceptives market covered in this report is segmented –

1) By Product: Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices

2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, 44 Years

3) By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels

Subsegments:

1) By Oral Contraceptive Pills: Combination Pills, Progestin-Only Pills

2) By Topical Contraceptives: Transdermal Patches, Gel Applications

3) By Injectables: Hormonal Injectables, Non-Hormonal Injectables

4) By Diaphragms: Silicone Diaphragms, Latex Diaphragms

5) By Vaginal Rings: Hormonal Rings, Non-Hormonal Rings

6) By Condoms: Male Condoms, Female Condoms

7) By Contraceptive Sponges: Non-Hormonal Sponges, Hormonal Sponges

8) By Subdermal Implants: Hormonal Implants, Non-Hormonal Implants

9) By Intra-Uterine Devices (IUDs): Hormonal IUDs, Copper IUDs

What Strategic Trends Are Transforming the Contraceptives Market?

Leading organizations in the contraceptives market are directing their efforts towards creating innovative contraceptive products such as Single Rod Subdermal Implant and Subcutaneous Injectable Contraceptives. The purpose of these advancements is to make contraceptives more user-friendly, increase their efficacy, and offer durable birth control solutions. They aim to reduce the frequency of dosage intake, increase ease of access, and limit side effects. This strategy provides more trustworthy and private contraceptive alternatives for those aiming to control their reproductive health better. For example, The Health and Family Welfare Ministry, a government institution in India, unveiled two new strategies – Single Rod Subdermal Implant and Subcutaneous Injectable Contraceptive in October 2023. These strategies, which are part of the National Family Planning Programme, aim to better health outcomes for mothers and babies. Through these new contraceptives, the goal is to decrease the rate of maternal and infant illnesses and deaths by offering more choices for family planning. This move is part of a wider plan to enhance reproductive health services in Karnataka, ensuring that women can access safe and efficient contraceptive options.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Which Global Regions Offer the Highest Growth in the Contraceptives Market?

North America was the largest region in the contraceptives market in 2024 and is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6920

This Report Delivers Insight On:

1. How big is the contraceptives market, and how is it changing globally?

2. Who are the major companies in the contraceptives market, and how are they performing?

3. What are the key opportunities and risks in the contraceptives market right now?

4. Which products or customer segments are growing the most in the contraceptives market?

5. What factors are helping or slowing down the growth of the contraceptives market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model